Antibiotic prophylaxis in interventional radiology

Journal of Vascular and Interventional Radiology

Volumn 15, Issue 6, 2004, Pages 547-556

  Ryan, J Mark ^a   Ryan, Barbara M ^b   Smith, Tony P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AVOPARCIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFAZOLIN; CEFOPERAZONE; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; GENTAMICIN; IMIPENEM; LINEZOLID; MEROPENEM; METRONIDAZOLE; MONOBACTAM DERIVATIVE; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; STREPTOMYCIN; SULTAMICILLIN; TAZOBACTAM; VANCOMYCIN;

ANAPHYLAXIS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BILIARY TRACT SURGERY; BRONCHOSPASM; CHEMOEMBOLIZATION; CLINICAL RESEARCH; DECISION MAKING; DISEASE ASSOCIATION; DRUG CHOICE; DRUG CROSS REACTIVITY; DRUG HYPERSENSITIVITY; DRUG USE; HUMAN; HYPOTENSION; IMMUNE DEFICIENCY; INFECTION; INFECTION RATE; INFECTION RISK; INTERVENTIONAL RADIOLOGY; LARYNX SPASM; MINIMALLY INVASIVE SURGERY; POSTOPERATIVE INFECTION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RASH; REVIEW; SIDE EFFECT; STANDARD; URTICARIA; UTERINE ARTERY EMBOLIZATION; VALIDATION PROCESS; VIRULENCE;

EID: 1842624627     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.000024942.58200.5E     Document Type: Review

References (83)

1. Spies JB, Rosen RJ, Lebovitz AS. Antibiotic prophylaxis in vascular and interventional radiology: a rational approach. Radiology 1988; 166:381-387.
2. McDermott VG, Schuster MG, Smith TP. Antibiotic prophylaxis in vascular and interventional radiology. AJR Am J Roentgenol 1997; 169:31-38.
3. Dravid VS, Gupta A, Zegel HG, Morales AV, Rabinowitz B, Freiman DB. Investigation of antibiotic prophylaxis usage for vascular and nonvascular interventional procedures. J Vasc Interv Radiol 1998; 9:401-406.
4. Wenzel PR. Preoperative antibiotic prophylaxis. N Engl J Med 1992; 326:337-339.
5. Sanchez-Manuel FJ, Seco-Gil JL. Antibiotic prophylaxis for hernia repair. Cochrane Database System Review 2003; 2:CD0033769.
6. Koc M, Zulfikaroglu B, Kece C, Ozalp N. A prospective randomized study of prophylactic antibiotics in elective laparoscopic cholecystectomy. Surg Endosc 2003; 17:1716-1718.
7. Leone M, Albanese J, Tod M, et al. Ceftriaxone (1g intravenously) penetration into abdominal tissues when administered as antibiotic prophylaxis during nephrectomy. J Chemother 2003; 15:139-142.
8. Goldman DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant organisms in hospitals: a challenge to hospital leadership. JAMA 1996; 275:234-240.
9. Jones RN, Phaller MA. Bacterial resistance; a worldwide problem. Diag Microbiol Infect Dis 1998; 31:379-388.
10. National nosocomial infections surveillance (NNIS) system report. Data summary from January 1992-April 2000. Am J Infect Control 2000; 28:429-448.
11. Klare I, Badstubner D, Konstabel C, Bohme G, Claus H, Witte W. Decreased incidence of VanA-type VRE isolated from poultry meat and from fecal samples in humans in the community after discontinuation of avoparcin usage in animal husbandry. Microb Drug Resist 1999; 5:45-52.
12. Chiew YF. Can susceptibility to an antimicrobial be restored by halting its use. The case of streptomycin versus Enterobacteriaceae. J Antimicrobial Chemother 1998; 41:247-251.
13. Boneca IG, Chiosis G. Vancomycin resistance: occurrence, mechanisms and strategies to combat it. Expert Opin Ther Targets 2003; 7:311-328.
14. Dzidic S, Bedekovic V. Horizontal gene transfer-emerging multidrug resistance in hospital bacteria. Acta Pharmacol Sin 2003; 24:519-526.
15. Cunha BA. Antimicrobial selection in the penicillin-allergic patient. Drugs Today 2001; 37:377-383.
16. Burke JF. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 1961; 50:161-168.
17. Stone HH, Hooper CA, Kolb LD, Geheber CE, Dawkins CE. Antibiotic prophylaxis in gastric, biliary, and colonic surgery. Ann Surg 1976; 184:443-452.
18. Classen DC, Evans RS, Pestotnik SL. The timing of prophylactic administration of antibiotics and the risk of surgical wound infection. N Engl J Med 1992; 326:281-286.
19. Stone HH, Haney BB, Kolb LD, Geheber CE, Hooper CA. Prophylactic and preventive antibiotic therapy, timing, duration and economics. Ann Surg 1979; 189:691-699.
20. Nelson CL, Green TG, Porter RA. One day versus seven days of preventive antibiotic therapy in orthopedic surgery. Clin Orthop 1983; 176:258-263.
21. DiPiro JT, Cheung RP, Bowden TA, Mansberger JA. Single dose systemic antibiotic prophylaxis of surgical wound infections. Am J Surg 1986; 152:552-559.
22. Thadepalli H, Mandal AK. Antibiotic prophylaxis in the surgical patient. Infez Med 1998; 6:71-80.
23. Pron G, Mocarski E, Cohen M, et al. Hysterectomy for complications after uterine artery embolization for leiomyoma: results of a Canadian multicenter clinical trial. J Am Assoc Gynecol Laparosc 2003; 10:99-106.
24. Walker WJ, Pelage JP. Uterine artery embolization in symptomatic fibroids: clinical results in 400 women with imaging follow up. BJOG 2002; 109:1262-1272.
25. Ryan JM, Gainey M, Glasson J, Doherty J, Smith TP. Simplified pain protocol after uterine artery embolization. Radiology 2002; 224:610-612.
26. Siskin GP, Stainken BF, Dowling K, Meo P, Ahn J, Dolen EG. Outpatient uterine artery embolization for symptomatic uterine fibroids: experience in 49 patients. J Vasc Interv Radiol 2000; 11:305-311.
27. Katsumori T, Nakajima K, Mihara T, Tokuhiro M. Uterine artery embolization using gelatin sponge particles alone for symptomatic fibroids. AJR Am J Roentgenol 2002; 178:135-139.
28. Pron G, Bennett J, Common A, et al. Technical results and effects of operator experience on uterine artery embolization for fibroids: The Ontario Uterine Fibroid Embolization Trial. The Ontario UFE Collaborative Group. J Vascular and Interventional Radiology 2003; 14:545-554.
29. Mehta H, Sandhu C, Matson M, Belli A-M. Review of re-admissions due to complications form uterine fibroid embolization. Clin Rad 2002; 57:1122-1124.
30. Walker W, Green A, Sutton C. Bilateral uterine artery embolization for myomata: results, complications and failures. Min Invas Ther Allied Technol 1999; 8:449-454.
31. Vashisht A, Studd J, Carey A, Burn P. Fatal septicemia after fibroid embolization. Lancet 1999; 354;307-308.
32. de Blok S, de Vries C, Prinssen HM, Blaauwgeers HL, Jorna-Meijer LB. Fatal sepsis after uterine artery embolization with microspheres. J Vasc Interv Radiol 2003; 14:779-783.
33. Freedman AM, Sanyal AJ, Tisnado J, et al. Complications of transjugular intrahepatic portosystemic shunts: a comprehensive review. Radiographics 1993; 13:1185-1210.
34. Sanyal AJ, Reddy KR. Vegetative infection of transjugular intrahepatic portosystemic shunts. Gastroenterology 1998; 115:110-115.
35. Schiano TD, Atillasoy E, Fiel MI, et al. Fatal fungaemia resulting from an infected transjugular intrahepatic portosystemic shunt stent. Am J Gastroenterol 1997; 92:709-710.
36. DeSimone JA, Beavis KG, Eschelman DJ, Henning KJ. Sustained bacteremia associated with transjugular intrahepatic portosystemic shunt (TIPS). Clin Infect Dis 2000; 30:384-386.
37. Armstrong PK, MacLeod C. Infection of transjugular intrahepatic portosystemic shunt devices: three cases and a review of the literature. Clin Infect Dis 2003; 36:407-412.
38. Brown RS, Brumage L, Yee HF, et al. Enterococcal bacteremia after transjugular intrahepatic portosystemic shunts (TIPS). Am J Gastroenterol 1998; 93:636-639.
39. Deibert P, Schwarz S, Olschewski M, Siegerstetter V, Blum HE, Rossle M. Risk factors and prevention of early infection after implantation or revision of transjugular intrahepatic portosystemic shunts: results of a randomized study. Dig Dis Sci 1998; 43:1708-1713.
40. Yee AC, Ho C-S. Complications of percutaneous drainage: benign versus malignant diseases. AJR Am J Roentgenol 1987; 148:1207-1209.
41. Hamlin JA, Friedman M, Stein MG, Bray JF. Percutaneous biliary drainage: complications of 118 consecutive catheterizations. Radiology 1986; 158:199-202.
42. Funaki B, Zaleski GX, Straus CA, et al. Percutaneous biliary drainage in patients with nondilated intrahepatic ducts. AJR Am J Roentgenol 1999; 173:1541-1544.
43. Brody LA, Brown KT, Getrajdman GI, et al. Clinical factors associated with positive bile cultures during primary percutaneous biliary drainage. J Vasc Interv Radiol 1998; 9:572-578.
44. Clark CD, Picus D, Dunagan WC. Bloodstream infections after interventional procedures in the biliary tract. Radiology 1994; 191:495-499.
45. Thompson BF, Arguedas MR, Wilcox CM. Antibiotic prophylaxis prior to endoscopic retrograde cholangiopancreatography in patients with obstructive jaundice: is it worth the cost? Aliment Pharmacol Ther 2002; 16:727-734.
46. Sheen-Chen S, Chen W, Eng H, et al. Bacteriology and antimicrobial choice in hepatolithiasis. Am J Infect Control 2000; 28:298-301.
47. Cronan JJ, Horn DL, Marcello et al. Antibiotics and nephrostomy tube care: preliminary observations. Radiology 1989; 172:1043-1045.
48. Larsen E, Gasser T, Madsen P. Antibiotic prophylaxis in urologic surgery. Urol Clin North Am 1986; 13:591-604.
49. Ryan JM, Hahn PF, Boland GW, McDowell RK, Saini S, Mueller PR. Percutaneous gastrostomy with t-fastener gastropexy: results of 316 consecutive procedures. Radiology 1997; 203:496-500.
50. Chen C, Chen PJ, Yang PM. Clinical and microbiological features of liver abscess after transarterial embolization for hepatocellular carcinoma. Am J Gastroenterology 1997; 92:2257-2259.
51. de Baere T, Roche A, Amenabar JA, et al. Liver abscess formation after local treatment of liver tumors. Hepatology 1996; 23:1436-1440.
52. Kim W, Clark TW, Baum RA, Soulen MC. Risk factors for liver abscess formation after hepatic chemoembolization. J Vasc Interv Radiol 2001; 12:965-968.
53. Song SY, Chung JW, Han JK, et al. Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome. J Vasc Interv Radiol 2001; 12:313-320.
54. Geschwind JF, Kaushik S, Ramsey DE, Choti MA, Fishman EK, Kobeiter H. Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors. J Vasc Interv Radiol 2002; 13:1163-1166.
55. Spigos DG, Jonasson O, Mozes M, et al. Partial splenic embolization in the treatment of hypersplenism. AJR Am J Roentgenol 1979; 132:777-782.
56. Mayo-Smith WW, Dupuy DE, Parikh PM, Pezzullo JA, Cronan JJ. Imaging-guided percutaneous radio-frequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. AJR Am J Roentgenol 2003; 180:1503-1508.
57. Dupuy DE, Goldberg SN. Image-guided radiofrequency tumor ablation: challenges and opportunities-part II. J Vasc Interv Radiol 2001; 12:1135-1148.
58. Shawker TH, Kluge RM, Ayella RJ. Bacteremia associated with angiography. JAMA 1974; 229:1180-1182.
59. Meyer P, Reizine D, Aymard A, Guerin JM, Merland JJ, Habib Y. Septic complications in interventional radiology: evaluation of risk and preventive measures. Preliminary studies. J Intervent Rad 1988; 3:73-75.
60. Hearn AT, James KV, Lohr JM, et al. Endovascular stent infection with delayed bacterial challenge. Am J Surg 1997; 174:157-159.
61. Dieter RS. Coronary artery stent infection. Clin Cardiol 2000; 23:808-810.
62. Malek AM, Higashida RT, Reilly LM, et al. Cardiovasc Intervent Radiol 2000; 23:57-60.
63. Leroy O, Martin E, Prat A, et al. Fatal infection of coronary stent implantation. Cathet Cardiovasc Diagn 1996; 39:168-170.
64. Deitch JS, Hansen KJ, Regan JD, Burkhart JM, Ligush J. Infected renal artery pseudoaneurysm and mycotic aortic aneurysm after percutaneous transluminal renal artery angioplasty and stent placement in a patient with a solitary kidney. J Vasc Surg 1998; 28:340-344.
65. Chalmers N, Eadington DW, Gandanhamo D, Gillespie IN, Ruckley CV. Case report: infected false aneurysm at the site of an iliac stent. Br J Radiol 1993; 66:946-948.
66. Liu P, Dravid V, Freiman D, Zegel H, Weinberg D. Persistent iliac endarteritis with pseudoaneurysm formation following balloon-expandable stent placement. Cardiovasc Intervent Radiol 1995; 18:39-42.
67. Deiparine MK, Ballard JL, Taylor FC, Chase DR. Endovascular stent infection. J Vasc Surg 1996; 23:529-533.
68. Bunt TJ, Gill HK, Smith DC, Taylor FC. Infection of a chronically implanted iliac artery stent. Ann Vasc Surg 1997; 11:529-532.
69. McCready RA, Siderys H, Pittman JN, et al. Septic complications after cardiac catheterization and percutaneous transluminal coronary angioplasty. J Vasc Surg 1991; 14:170-174.
70. Carey D, Martin JR, Moore CA, Valentine MC, Nygaard TW. Complications of femoral artery closure devices. Catheter Cardiovasc Interv 2001; 52:3-7.
71. Becker GJ, Kovacs M, Mathison MN, et al. Risk stratification and outcomes of transluminal endografting for abdominal aortic aneurysm: 7-year experience and long-term follow-up. J Vasc Interv Radiol 2001; 12:1033-1046.
72. Heikkinen L, Valtonen M, Lepantalo M, Saimanen E, Jarvinen A. Infrarenal endoluminal bifurcated stent graft infected with Listeria monocytogenes. J Vasc Surg 1999; 29:554-556.
73. Katzen BT, Becker GJ, Mascioli CA, et al. Creation of a modified angiography (endovascular) suite for transluminal endograft placement and combined interventional-surgical procedures. J Vasc Interv Radiol 1996; 7:161-167.
74. Eliason JL, Guzman RJ, Passman MA, Naslund TC. Infected endovascular graft secondary to coil embolization of endoleak: a demonstration of the importance of operative sterility. Ann Vasc Surg 2002; 16:562-565.
75. Kurimoto Y, Tsuchida Y, Saito J, Yama N, Narimatsu E, Asai Y. Emergency endovascular stent-grafting for infected pseudoaneurysm of brachial artery. Infection 2003; 31:186-188.
76. Openshaw KL, Picus D, Hicks ME, Darcy MD, Vesely TM, Picus J. Interventional radiologic placement of Hohn central venous catheters: results and complications in 100 consecutive patients. J Vasc Interv Radiol 1994; 5:111-115.
77. Miller DL, O'Grady NP. Guidelines for the prevention of intravascular catheter-related infections: recommendations relevant to interventional radiology. J Vasc Interv Radiol 2003; 14:133-136.
78. Whigham CJ, Goodman CJ, Fisher RG, Greenbaum MC, Thomby JI, Thomas JW. Infectious complications of 393 peripherally implantable venous access devices in HIV-positive and HIV-negative patients. J Vasc Interv Radiol 1999; 10:71-77.
79. Van DE, Van Woensel JB. Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients (Cochrane Review). Cochrane Database System Review 2003; 2:CD003295.
80. Brodwater BK, Silber JS, Smith TP, et al. Conversion of indwelling chest port catheters to tunneled central venous catheters. J Vasc Interv Radiol 2000; 11:1137-1142.
81. Philipneri M, Al Aly Z, Amin K, Gellens ME, Bastani B. Routine replacement of tunneled, cuffed, hemodialysis catheters eliminates paraspinal/vertebral infections in patients with catheter-associated bacteremia. Am J Nephrol 2003; 23:202-207.
82. Darouiche RO. Antimicrobial approaches for preventing infections associated with surgical implants. Clin Infect Dis 2003; 36:1284-1289.
83. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Am J Infect Control 1999; 27:97-132.